Molbio Diagnostics IPO is a Mainboard public issue with a total size of ₹939.70 Crore. The IPO is priced in the range of ₹768 to ₹807 per equity share and will open for subscription on August 10, 2026, closing on August 12, 2026. Investors can bid for a minimum lot of 18 shares. The shares are proposed to be listed on both BSE and NSE, while the allotment is expected to be finalized on August 13, 2026, followed by listing on August 17, 2026. The company plans to utilize the proceeds for business expansion, research and development initiatives, manufacturing infrastructure enhancement, and general corporate purposes.
Molbio Diagnostics IPO GMP Today
Molbio Diagnostics IPO last GMP is ₹125, last updated August 16 2026 02:42 pm. With the upper price band of ₹807, Molbio Diagnostics IPO’s Estimated listing is ₹932 (cap price + today’s GMP). Tha expected percentage gain/loss per share is 15.49%
We update the GMP daily. Based on grey market activity over the last 11 session, the IPO’s GMP is trending upward today, indicating expectations of a strong listing. During this period, the GMP ranged from a low of ₹115 to a high of ₹156 . stay with us for the latest Molbio Diagnostics IPO GMP updates, daily price trends, and expected listing price.
| GMP Date | IPO Price | GMP | EST. Listing Price | EST. Profit* | Last Updated |
|---|---|---|---|---|---|
| 16-08-2026 | ₹807 | ₹125 | ₹932(15.49%) | ₹2250 | 14:42 |
| 15-08-2026 | ₹807 | ₹115 | ₹922(14.25%) | ₹2070 | 10:02 |
| 14-08-2026 | ₹807 | ₹156 | ₹963(19.33%) | ₹2808 | 10:31 |
| 13-08-2026 | ₹807 | ₹156 | ₹963(19.33%) | ₹2808 | 15:39 |
| 12-08-2026 | ₹807 | ₹138 | ₹945(17.10%) | ₹2484 | 10:18 |
| 11-08-2026 | ₹807 | ₹122 | ₹929(15.12%) | ₹2196 | 15:20 |
| 10-08-2026 | ₹807 | ₹125 | ₹932(15.49%) | ₹2250 | 14:57 |
| 09-08-2026 | ₹807 | ₹122 | ₹929(15.12%) | ₹2196 | 16:32 |
| 08-08-2026 | ₹807 | ₹130 | ₹937(16.11%) | ₹2340 | 15:21 |
| 07-08-2026 | ₹807 | ₹180 | ₹987(22.30%) | ₹3240 | 14:56 |
| 06-08-2026 | ₹807 | ₹220 | ₹1027(27.26%) | ₹3960 | 15:32 |
Molbio Diagnostics IPO Details
| IPO Open Date | 10-08-2026 |
| IPO Close Date | 12-08-2026 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹768 to ₹807 Per Share |
| Issue Size | Approx ₹939.70 cr. |
| Fresh Issue | Approx ₹200 cr. |
| Offer For Sale | Approx 91,66,000 |
| Issue Type | Book Built Issue |
| IPO Listing | NSE,BSE |
Issue Reservation
| Investor Category | Shares Offered % |
|---|---|
| Retail Shares Offered | 35% |
| NII Shares Offered | 15% |
| QIB Shares Offered | 50% |
Molbio Diagnostics IPO Market Lot
The Molbio Diagnostics IPO minimum market lot is 18 shares with ₹ 14,526 application amount. The retail investors can apply up-to 13 lots with 234 shares of ₹1,88,838 amount.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 18 | ₹14,526 |
| Retail Maximum | 13 | 234 | ₹1,88,838 |
| S-HNI Minimum | 14 | 252 | ₹2,03,364 |
| S-HNI Maximum | 68 | 1224 | ₹9,87,768 |
| B-HNI Minimum | 69 | 1242 | ₹10,02,294 |
Molbio Diagnostics IPO Anchor Investors
| Anchor Bidding Date | 07-08-2026 |
| Shares Offered | 34,87,717 Share |
| Lock-in period end date 50% shares(30 Days) | 12-09-2026 |
| Lock-in period end date 50% shares (90 Days) | 11-11-2026 |
Molbio Diagnostics IPO Dates
The Molbio Diagnostics IPO Open date is August 10 and the close date is August 12. The Molbio Diagnostics IPO allotment will be finalized on August 13 and the IPO listing on August 17.
| IPO Open Date: | 10-08-2026 |
| IPO Close Date: | 12-08-2026 |
| Basis of allotment: | 13-08-2026 |
| Refunds: | 14-08-2026 |
| Credit to Demat Account: | 14-08-2026 |
| IPO Listing Date: | 17-08-2026 |
Molbio Diagnostics Pros and Cons Analysis
Pros
1️⃣Unique Truenat molecular diagnostics platform.
2️⃣WHO-backed technology with strong market presence.
Cons
1️⃣High dependence on government healthcare programs.
2️⃣Supply chain disruptions may affect operations.
Promoters and Holding Pattern
The Promoters of Molbio Diagnostics Limited are Dr. Chandrasekhar Bhaskaran Nair, Sriram Natarajan, Sangeetha Sriram, Shiva Sriram, Sowmya Sriram and Exxora Trading LLP.
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 52,597,450 | 46.65% |
| Promoter Holding Post Issue | 43,431,450 | 37.69% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
|---|---|
| Capital expenditure towards development of research and innovation infrastructure, including Centre of Excellence and office space | ₹118.08 cr. |
| Capital expenditure for procurement of machinery, equipment and production assets across manufacturing units | ₹ 79.04 cr. |
| General corporate purposes | ₹- |
About Molbio Diagnostics Ltd
Molbio Diagnostics Limited is an Indian molecular diagnostics company focused on developing innovative and accessible healthcare testing solutions. Founded in 2000, the company is known for its advanced diagnostic technologies that help detect infectious and other diseases quickly and accurately.
The company’s flagship product, Truenat, is a portable molecular testing platform designed to provide fast and reliable results, even in remote and resource-limited locations. Molbio serves healthcare providers, laboratories, hospitals, and government health programs through its range of diagnostic instruments and test kits.
Over the years, Molbio has built a strong presence in the diagnostics industry through continuous research and development, product innovation, and a focus on improving healthcare accessibility. The company aims to expand its diagnostic capabilities and strengthen its market position by investing in technology, infrastructure, and manufacturing facilities.
Molbio Diagnostics IPO Company Financial Report
| Period Ended | Revenue | Expense | Pat | Assets |
|---|---|---|---|---|
| 2024 | ₹840.66 | ₹657.83 | ₹83.54 | ₹1221.06 |
| 2025 | ₹1027.94 | ₹820.41 | ₹138.58 | ₹1461.56 |
| 2026 | ₹1455.17 | ₹1221.35 | ₹164.14 | ₹2148.42 |
Molbio Diagnostics IPO Valuation – FY2026
Check Molbio Diagnostics IPO valuations detail like Earning Per Share (EPS), Price/Earning (P/E Ratio), Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
|---|---|
| ROE | 15.59% |
| ROCE | 17.55% |
| EBITDA Margin | 22.56% |
| PAT Margin | 11.28% |
| Debt to equity ration | 0.36 |
| Earning Per Share(EPS) | ₹14.77 |
| P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 14.55% |
| Net Asset Value(NAV) | ₹101.51 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW | NAV | Income |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | 30.24 | 62.20 | 20.78% | 145.00 | 2762.91 cr. |
| Metropolis Healthcare Ltd | 9.19 | 63.72 | 12.56% | 72.98 | 1645.85 cr. |
| Poly Medicure Ltd | 31.79 | 52.61 | 10.37% | 306.45 | 1875.26 cr. |
| Vijaya Diagnostics Centre Ltd | 16.81 | 81.02 | 18.07% | 93.02 | 814.20 cr. |
Molbio Diagnostics IPO Lead Managers aka Merchant Bankers
- Kotak Mahindra Capital Co. Ltd.
- IIFL Capital Services Ltd.
- Jefferies India Pvt. Ltd.
- Motilal Oswal Investment Advisors Ltd.
Molbio Diagnostics Company Address
Molbio Diagnostics Ltd.
Plot No. L-46
Phase II-D, Verna Industrial Area
Verna, Salcete
South Goa, Goa, 403722
Phone: +91 8326724888
Email: investors@molbiodiagnostics.com
Website: http://www.molbiodiagnostics.com
Molbio Diagnostics IPO Registrar
Registrar Name: KFin Technologies Limited
Contact Person: M. Murali Krishna
Phone: +91 40 6716 2222 / 1800 309 4001
Email: molbio.ipo@kfintech.com
Website: www.kfintech.com
FAQs
What type of IPO is Molbio Diagnostics offering?
Molbio Diagnostics is launching a Mainboard IPO to raise funds from public investors and expand its business operations.
When can investors apply for the Molbio Diagnostics IPO?
The subscription window will remain open from August 10, 2026, to August 12, 2026.
How is the IPO reserved among different investor categories?
The issue allocation is divided into 50% for QIBs, 15% for NIIs, and 35% for Retail Investors.
What are the available methods to apply for this IPO?
Investors can submit their applications through ASBA banking services, UPI-based applications, or offline forms provided by stockbrokers.
What is the total size of the Molbio Diagnostics IPO?
The company plans to mobilize approximately ₹939.70 Crore through this public offering.
What is the price range fixed for the IPO?
The equity shares are being offered in a price band of ₹768 to ₹807 per share.
What is the minimum investment requirement for retail investors?
Investors need to apply for at least 18 shares, requiring a minimum investment of ₹14,526 at the upper price band.
When is the IPO allotment expected to be finalized?
The basis of allotment is scheduled to be completed on August 13, 2026.
On which date are the shares expected to be listed?
The shares are proposed to debut on the stock exchanges on August 17, 2026.
Where will Molbio Diagnostics shares be listed?
After the IPO process is completed, the company’s shares are expected to be traded on both BSE and NSE.
Disclaimer
I am not a SEBI-registered Research Analyst, Investment Adviser, or any other SEBI-regulated financial professional. The information provided on this website regarding IPOs, GMP, stock markets, and other financial topics is for educational and informational purposes only.
The content published on this website should not be considered financial advice, investment advice, or a recommendation to buy, sell, or hold any security. Investors should conduct their own research and consult a SEBI-registered financial advisor before making any investment decisions.